The limited available data indicates that IL-4, as an anti-inflammatory factor, may induce the differentiation of anti-inflammatory microglia (also known as M2 microglia) through the STAT6 signaling pathway and mediate the phagocytosis of hematoma components. The gene discussed is IL4; the disease is hematoma.